RhumbLine Advisers’s AdaptHealth AHCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.83M | Sell |
300,018
-3,136
| -1% | -$29.6K | ﹤0.01% | 1696 |
|
|
2025
Q1 | $3.29M | Sell |
303,154
-9,956
| -3% | -$108K | ﹤0.01% | 1569 |
|
|
2024
Q4 | $2.98M | Buy |
313,110
+1,691
| +0.5% | +$16.1K | ﹤0.01% | 1681 |
|
|
2024
Q3 | $3.5M | Buy |
311,419
+40,386
| +15% | +$454K | ﹤0.01% | 1608 |
|
|
2024
Q2 | $2.71M | Buy |
271,033
+3,498
| +1% | +$35K | ﹤0.01% | 1721 |
|
|
2024
Q1 | $3.08M | Buy |
267,535
+2,332
| +0.9% | +$26.8K | ﹤0.01% | 1675 |
|
|
2023
Q4 | $1.93M | Buy |
265,203
+14,503
| +6% | +$106K | ﹤0.01% | 1921 |
|
|
2023
Q3 | $2.28M | Buy |
250,700
+31,061
| +14% | +$283K | ﹤0.01% | 1793 |
|
|
2023
Q2 | $2.67M | Sell |
219,639
-11,986
| -5% | -$146K | ﹤0.01% | 1744 |
|
|
2023
Q1 | $2.88M | Buy |
231,625
+10,988
| +5% | +$137K | ﹤0.01% | 1620 |
|
|
2022
Q4 | $4.24M | Sell |
220,637
-8,814
| -4% | -$169K | 0.01% | 1377 |
|
|
2022
Q3 | $4.31M | Buy |
229,451
+127,301
| +125% | +$2.39M | 0.01% | 1322 |
|
|
2022
Q2 | $1.84M | Buy |
102,150
+9,902
| +11% | +$179K | ﹤0.01% | 1803 |
|
|
2022
Q1 | $1.48M | Sell |
92,248
-9,254
| -9% | -$148K | ﹤0.01% | 1960 |
|
|
2021
Q4 | $2.48M | Buy |
101,502
+593
| +0.6% | +$14.5K | ﹤0.01% | 1761 |
|
|
2021
Q3 | $2.35M | Sell |
100,909
-3,486
| -3% | -$81.2K | ﹤0.01% | 1815 |
|
|
2021
Q2 | $2.86M | Buy |
104,395
+28,938
| +38% | +$793K | ﹤0.01% | 1765 |
|
|
2021
Q1 | $2.77M | Buy |
75,457
+49,975
| +196% | +$1.84M | ﹤0.01% | 1748 |
|
|
2020
Q4 | $957K | Buy |
25,482
+2,942
| +13% | +$110K | ﹤0.01% | 2151 |
|
|
2020
Q3 | $492K | Buy |
+22,540
| New | +$492K | ﹤0.01% | 2298 |
|